the role of rwd in tumor agnostic drug development | researchx
Published 2 years ago • 557 plays • Length 1:00:29Download video MP4
Download video MP3
Similar videos
-
59:16
bridging the divide: opportunities to integrate clinical research into everyday care
-
24:24
flatiron health goes global: oncology rwe platform aims to transform cancer treatment worldwide
-
10:05
new dosing regimen for cetuximab
-
29:08
use of ehr data in drug development – applications and key considerations
-
40:59
epidemiology seminar | flatiron health database | uab school of public health
-
36:04
unlocking the power of tumor-agnostic therapy: a path to personalized cancer care
-
1:04:42
exploring the rise of rwe in regulatory submissions
-
57:55
session 3: frameworks for rwe and recommendations for real world endpoints
-
22:19
accelerating cancer research with r
-
30:52
founder stories: zach weinberg, co-founder of flatiron health & using data to cure cancer
-
1:58
unmet needs in sr-agvhd and tr-agvhd
-
18:33
zach weinberg, flatiron health: founder's story
-
0:57
dr. craig o'dell, o.d.
-
1:01
meet ophthalmologist ron adelman, md, mph, mba, facs
-
40:43
7. li-rads; lr- tumor in vein (tiv) - part 1. by dr. alessandro furlan.
-
52:16
uofl dept. of medicine grand rounds: dr. adam rojan
-
2:24
paul r. helft, md, hematology - oncology
-
1:05
rohan maniar, md, hematology - oncology